Genetic Medicines Company Passage Bio To Make U.S. Trading Debut On Feb.28
The Philadelphia-based Passage Bio is slated to debut on the Nasdaq Global Market under the symbol "PASG" on February 28,…
Börse:
16,155€
-78,74%
Echtzeit-Aktienkurs Medicines Company
Bid:
16,150€
Ask:
16,160€
Nachrichten zur Medicines Company Aktie
UPDATE 1-Companies in pharmaceutical supply chain develop system to track counterfeit drugs
Some of the industrys largest
pharmaceutical companies, including Pfizer Inc and Eli
Lilly and Co, have developed a blockchain-based system
to track prescription…
Wave Life Sciences to Present Preclinical In Vivo and In Vitro Data for SNP3-Targeting Huntingtons Disease Program at CHDI Foundations 15th Annual HD Therapeutics Conference
CAMBRIDGE, Mass., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines…
Genetic medicines company Passage Bio to offer 7.4 million shares in IPO priced at $16 to $18 each
Genetic medicines company Passage Bio set the terms for its planned initial public offering on Tuesday, with plans to…